These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 27328919)

  • 1. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
    Bouaoun L; Sonkin D; Ardin M; Hollstein M; Byrnes G; Zavadil J; Olivier M
    Hum Mutat; 2016 Sep; 37(9):865-76. PubMed ID: 27328919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
    Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
    Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IARC TP53 database: new online mutation analysis and recommendations to users.
    Olivier M; Eeles R; Hollstein M; Khan MA; Harris CC; Hainaut P
    Hum Mutat; 2002 Jun; 19(6):607-14. PubMed ID: 12007217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
    Li VD; Li KH; Li JT
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):625-636. PubMed ID: 30542790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutations in human cancer: database reassessment and prospects for the next decade.
    Soussi T
    Adv Cancer Res; 2011; 110():107-39. PubMed ID: 21704230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations in human cancer: database reassessment and prospects for the next decade.
    Leroy B; Anderson M; Soussi T
    Hum Mutat; 2014 Jun; 35(6):672-88. PubMed ID: 24665023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutations in human cancers: origins, consequences, and clinical use.
    Olivier M; Hollstein M; Hainaut P
    Cold Spring Harb Perspect Biol; 2010 Jan; 2(1):a001008. PubMed ID: 20182602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UMD-p53 database: new mutations and analysis tools.
    Béroud C; Soussi T
    Hum Mutat; 2003 Mar; 21(3):176-81. PubMed ID: 12619103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing.
    Tikkanen T; Leroy B; Fournier JL; Risques RA; Malcikova J; Soussi T
    Hum Mutat; 2018 Jul; 39(7):925-933. PubMed ID: 29696732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
    Petitjean A; Achatz MI; Borresen-Dale AL; Hainaut P; Olivier M
    Oncogene; 2007 Apr; 26(15):2157-65. PubMed ID: 17401424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering.
    Soussi T; Leroy B; Devir M; Rosenberg S
    Hum Mutat; 2019 May; 40(5):516-524. PubMed ID: 30720243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics of brain tumors are associated with the presence and patterns of TP53 mutations: evidence from the IARC TP53 Database.
    Salnikova LE
    Neuromolecular Med; 2014 Jun; 16(2):431-47. PubMed ID: 24481542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel germline TP53 mutation p.Pro190Arg detected in a patient with lung and bilateral breast cancers.
    Krześniak M; Butkiewicz D; Rachtan J; Matuszczyk I; Grzybowska E; Rusin M
    Adv Med Sci; 2017 Sep; 62(2):207-210. PubMed ID: 28499267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical correlates of TP53 somatic mutations in cancer.
    Murnyák B; Hortobágyi T
    Oncotarget; 2016 Oct; 7(40):64910-64920. PubMed ID: 27626311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm.
    Soussi T
    Hum Mutat; 2014 Jun; 35(6):643-53. PubMed ID: 24478183
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Terradas M; Mur P; Belhadj S; Woodward ER; Burghel GJ; Munoz-Torres PM; Quintana I; Navarro M; Brunet J; Lazaro C; Pineda M; Moreno V; Capella G; Evans DGR; Valle L
    Gut; 2021 Jun; 70(6):1139-1146. PubMed ID: 32998877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations associated with aging-related rise in cancer incidence rates.
    Richardson RB
    Cell Cycle; 2013 Aug; 12(15):2468-78. PubMed ID: 23839036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
    Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
    Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools.
    Hainaut P; Hernandez T; Robinson A; Rodriguez-Tome P; Flores T; Hollstein M; Harris CC; Montesano R
    Nucleic Acids Res; 1998 Jan; 26(1):205-13. PubMed ID: 9399837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.